Cargando…
Development of Merkel Cell Carcinoma in a Patient Receiving Rituximab
Merkel cell carcinoma (MCC) is a rare, rapidly growing, and aggressive dermatological neoplasm. It is commonly reported in Caucasian ethnicities, and almost 50% of the patients have a concomitant malignancy and are on immunosuppressive chemotherapy. Here, we present a 79-year-old woman with a histor...
Autores principales: | Antonios, Bana, Karki, Ujjwal, Antonios, Kais, Ghimire, Bipin, Chisti, Mohammad Muhsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649309/ https://www.ncbi.nlm.nih.gov/pubmed/36394062 http://dx.doi.org/10.1155/2022/1814338 |
Ejemplares similares
-
Merkel cell carcinoma of unknown primary site; case presentation and review of the literature
por: Kontis, Elissaios, et al.
Publicado: (2015) -
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy
por: da Costa, Cesar Martins, et al.
Publicado: (2020) -
A Rare Case of Metastasis of Small Cell Carcinoma of Cervix to Breast
por: Yadav, Dhiraj, et al.
Publicado: (2015) -
Merkel cell carcinoma in an immunosuppressed patient
por: Góes, Heliana Freitas de Oliveira, et al.
Publicado: (2017) -
Merkel Cell Polyomavirus Infection in a Patient With Merkel Cell Carcinoma: A Case Report
por: Sadeghi, Farzin, et al.
Publicado: (2015)